ReviewWorld journal of hepatology2022

Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?

Eduardo Fassio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.